Prenylation Enhances Quercetin Uptake and Reduces Efflux in Caco-2 Cells and Enhances Tissue Accumulation in Mice Fed Long-Term1-3

Journal of Nutrition

Volumn 143, Issue 10, 2013, Pages 1558-1564

  Mukai, Rie ^a   Fujikura, Yutaka ^a   Murota, Kaeko ^b   Uehara, Mariko ^c   Minekawa, Shoko ^a   Matsui, Naoko ^a   Kawamura, Tomoyuki ^a   Nemoto, Hisao ^a   Terao, Junji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 PRENYL QUERCETIN; QUERCETIN; QUERCETIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIOACCUMULATION; CELL STRAIN CACO 2; CONTROLLED STUDY; DIETARY INTAKE; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG UPTAKE; EFFUSION; INTESTINE ABSORPTION; KIDNEY; LIPOPHILICITY; LIVER; LYMPH FLOW; MALE; METHYLATION; MONOLAYER CULTURE; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRENYLATION; RAT; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; TISSUE DISTRIBUTION;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CACO-2 CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; KIDNEY; LIVER; LYMPH; METHYLATION; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; PRENYLATION; QUERCETIN; RATS; RATS, WISTAR;

EID: 84885774936     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.176818     Document Type: Article

References (41)

1. Barron D, Ibrahim RK. Isoprenylated flavonoids: a survey. Phytochemistry. 1996;43:921-82.
2. Botta B, Vitali A, Menendez P, Misiti D, Delle Monache G. Prenylated flavonoids: pharmacology and biotechnology. Curr Med Chem. 2005; 12:717-39.
3. Huang X, Zhu D, Lou Y. A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells. Eur J Pharmacol. 2007;564:26-36.
4. Kuroyanagi M, Arakawa T, Hirayama Y, Hayashi T. Antibacterial and antiandrogen flavonoids from Sophora flavescens. J Nat Prod. 1999;62:1595-9.
5. Lee MH, Kim JY, Ryu JH. Prenylflavones from Psoralea corylifolia inhibit nitric oxide synthase expression through the inhibition of I-kappaB-alpha degradation in activated microglial cells. Biol Pharm Bull. 2005;28:2253-7.
6. Kretzschmar G, Zierau O, Wober J, Tischer S, Metz P, Vollmer G. Prenylation has a compound specific effect on the estrogenicity of naringenin and genistein. J Steroid Biochem Mol Biol. 2010;118:1-6.
7. Arung ET, Shimizu K, Tanaka H, Kondo R. 3-Prenyl luteolin, a new prenylated flavone with melanin biosynthesis inhibitory activity from wood of Artocarpus heterophyllus. Fitoterapia. 2010;81:640-3.
8. Mukai R, Horikawa H, Fujikura Y, Kawamura T, Nemoto H, Nikawa T, Terao J. Prevention of disuse muscle atrophy by dietary ingestion of 8-prenylnaringenin in denervated mice. PLoS ONE. 2012;7:e45048.
9. Sasaki K, Mito K, Ohara K, Yamamoto H, Yazaki K. Cloning and characterization of naringenin 8-prenyltransferase, a flavonoid-specific prenyltransferase of Sophora flavescens. Plant Physiol. 2008;146:1075-84.
10. Stevens JF, Taylor AW, Deinzer ML. Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography tandem mass spectrometry. J Chromatogr A. 1999; 832:97-107.
11. Jung HA, Moon HE, Oh SH, Kim BW, Sohn HS, Choi JS. Kinetics and molecular docking studies of kaempferol and its prenylated derivatives as aldose reductase inhibitors. Chem Biol Interact. 2012;197:110-8.
12. Chen SG, Chen JJ, Gao K. Prenylisoflavone derivatives from the roots of Hedysarum scoparium. Chem Pharm Bull (Tokyo). 2007;55:1181-4.
13. Wu Y, Luo Q, Sun C, Wang G, Chen Q, Guo Z, Zou X, Chen H. [Chemical constituents contained in Desmodium caudatum]. Zhongguo Zhong Yao Za Zhi. 2012;37:1788-92.
14. Murota K, Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys. 2003; 417:12-7.
15. Moon JH, Nakata R, Oshima S, Inakuma T, Terao J. Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. Am J Physiol Regul Integr Comp Physiol. 2000;279: R461-7.
16. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr. 2000;130:S2073-85.
17. Murota K, Terao J. Quercetin appears in the lymph of unanesthetized rats as its phase II metabolites after administered into the stomach. FEBS Lett. 2005;579:5343-6.
18. Bieger J, Cermak R, Blank R, de Boer VC, Hollman PC, Kamphues J, Wolffram S. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr. 2008;138:1417-20.
19. de Boer VC, Dihal AA, van der Woude H, Arts IC, Wolffram S, Alink GM, Rietjens IM, Keijer J, Hollman PC. Tissue distribution of quercetin in rats and pigs. J Nutr. 2005;135:1718-25.
20. Shen P, Wong SP, Yong EL. Sensitive and rapid method to quantify icaritin and desmethylicaritin in human serum using gas chromatographymass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;857:47-52.
21. Rad M, Humpel M, Schaefer O, Schoemaker RC, Schleuning WD, Cohen AF, Burggraaf J. Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. Br J Clin Pharmacol. 2006;62:288-96.
22. Pang Y, Nikolic D, Zhu D, Chadwick LR, Pauli GF, Farnsworth NR, van Breemen RB. Binding of the hop (Humulus lupulus L.) chalcone xanthohumol to cytosolic proteins in Caco-2 intestinal epithelial cells. Mol Nutr Food Res. 2007;51:872-9.
23. Yilmazer M, Stevens JF, Deinzer ML, Buhler DR. In vitro biotransformation of xanthohumol, a flavonoid from hops (Humulus lupulus), by rat liver microsomes. Drug Metab Dispos. 2001;29:223-31.
24. Kawamura T, Hayashi M, Mukai R, Terao J, Nemoto H. An efficient method for c8-prenylation of flavonols and flavanones. Synthesis. 2012;44:1308-14.
25. Shirai M, Moon JH, Tsushida T, Terao J. Inhibitory effect of a quercetin metabolite, quercetin 3-O-beta-D-glucuronide, on lipid peroxidation in liposomal membranes. J Agric Food Chem. 2001;49:5602-8.
26. Murota K, Shimizu S, Chujo H, Moon JH, Terao J. Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Arch Biochem Biophys. 2000; 384:391-7.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
28. Tammela P, Laitinen L, Galkin A, Wennberg T, Heczko R, Vuorela H, Slotte JP, Vuorela P. Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles. Arch Biochem Biophys. 2004;425:193-9.
29. Mullen W, Edwards CA, Crozier A. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr. 2006;96:107-16.
30. O'Leary KA, Day AJ, Needs PW, Mellon FA, O'Brien NM, Williamson G. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol. 2003;65:479-91.
31. Brand W, van der Wel PA, Rein MJ, Barron D, Williamson G, van Bladeren PJ, Rietjens IM. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. Drug Metab Dispos. 2008;36:1794-802.
32. Zhang L, Lin G, Kovacs B, Jani M, Krajcsi P, Zuo Z. Mechanistic study on the intestinal absorption and disposition of baicalein. Eur J Pharm Sci. 2007;31:221-31.
33. Karawajczyk A, Drgan V, Medic N, Oboh G, Passamonti S, Novic M. Properties of flavonoids influencing the binding to bilitranslocase investigated by neural network modelling. Biochem Pharmacol. 2007;73: 308-20.
34. Passamonti S, Terdoslavich M, Franca R, Vanzo A, Tramer F, Braidot E, Petrussa E, Vianello A. Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Curr Drug Metab. 2009;10:369-94.
35. Passamonti S, Vrhovsek U, Vanzo A,Mattivi F. The stomach as a site for anthocyanins absorption from food. FEBS Lett. 2003;544:210-3.
36. Vanzo A, Vrhovsek U, Tramer F, Mattivi F, Passamonti S. Exceptionally fast uptake and metabolism of cyanidin 3-glucoside by rat kidneys and liver. J Nat Prod. 2011;74:1049-54.
37. Mullen W, Rouanet JM, Auger C, Teissedre PL, Caldwell ST, Hartley RC, Lean ME, Edwards CA, Crozier A. Bioavailability of [2-(14)C] quercetin-4#-glucoside in rats. J Agric Food Chem. 2008;56:12127-37.
38. Ueno I, Nakano N, Hirono I. Metabolic fate of [14C] quercetin in the ACI rat. Jpn J Exp Med. 1983;53:41-50.
39. Dietrich CG, Geier A, Oude Elferink RP. ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut. 2003;52:1788-95.
40. Zhu BT, Ezell EL, Liehr JG. Catechol-O-methyltransferase-catalyzed rapid O-methylation of mutagenic flavonoids.Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo. J Biol Chem. 1994;269:292-9.
41. Cao G, Sofic E, Prior RL. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med. 1997; 22:749-60.